Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 709,171 | 689,892 | 652,800 | 580,656 | 517,553 |
| Receivables | 126,477 | 106,409 | 65,863 | 71,265 | 65,476 |
| Inventories | 37,166 | 28,029 | 18,650 | 19,778 | 19,541 |
| TOTAL | $894,030 | $852,453 | $758,739 | $685,718 | $623,609 |
| Non-Current Assets | |||||
| PPE Net | 1,037 | 1,077 | 1,149 | 1,239 | 1,354 |
| Investments And Advances | 22,536 | 19,167 | 21,256 | 24,208 | 21,564 |
| Intangibles | 131,674 | 128,639 | 137,983 | 147,327 | 156,672 |
| Other Non-Current Assets | 54,702 | 50,266 | 52,788 | 50,380 | 48,212 |
| TOTAL | $209,949 | $199,149 | $213,176 | $223,154 | $227,802 |
| Total Assets | $1,103,979 | $1,051,602 | $971,915 | $908,872 | $851,411 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,202 | 9,096 | 5,528 | 11,197 | 16,593 |
| Accrued Expenses | 135,950 | 119,639 | 107,479 | 100,452 | 104,085 |
| TOTAL | $147,152 | $128,735 | $113,007 | $111,649 | $120,678 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,559 | 2,622 | 2,881 | 2,940 | 3,101 |
| TOTAL | $2,559 | $2,622 | $2,881 | $2,940 | $3,101 |
| Total Liabilities | $149,711 | $131,357 | $115,888 | $114,589 | $123,779 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,124 | 122,912 | 122,391 | 121,975 | 121,450 |
| Common Shares | 123 | 123 | 122 | 122 | 121 |
| Retained earnings | 474,188 | 446,789 | 394,006 | 341,898 | 285,161 |
| Other shareholders' equity | 0 | 0 | 31 | -17 | 64 |
| TOTAL | $954,268 | $920,245 | $856,027 | $794,283 | $727,632 |
| Total Liabilities And Equity | $1,103,979 | $1,051,602 | $971,915 | $908,872 | $851,411 |